课题基金 / 基金详情

Molecular mechanisms of telomerase activation by human papillomavirus E6

Molecular mechanisms of telomerase activation by human papillomavirus E6
人乳头瘤病毒E6激活端粒酶的分子机制
批准号:
11138267
负责人:
KIYONO Tohru
金额:
$4.8万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research on Priority Areas (A)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 --

项目摘要

项目成果

KIYONO Tohru的其他基金

相似基金

相关文献

中文摘要
翻译
端粒酶的激活是超过85%的所有癌症的共同和特异性特征。除了端粒酶逆转录酶亚单位(TERT)外,“高危”人乳头瘤病毒的E6基因和c-myc癌基因也被认为能激活端粒酶。为了阐明端粒酶的激活机制,我们检测了这些基因在端粒酶激活中的作用,阐明了以下几点:1。HPV 16 E6和c-myc均通过诱导端粒酶的表达来激活端粒酶。E6和c-myc均不能激活原代人成纤维细胞的端粒酶活性.在原代人乳腺上皮细胞(HMEC)中,E6可激活端粒酶而不增加Myc,而E7可增加Myc水平但不能激活端粒酶。E6和E7联合表达对端粒酶的激活作用强于E6单独表达.利用酵母三杂交系统,我们分离到了能与E6/E6 AP复合物结合的新的细胞蛋白的cDNA,并制备了部分蛋白的抗血清。E6使转录因子Myc通过改变其染色质结构进入TERT位点.在表达E6和E7的HMEC中,E6和E7分别通过打开染色质结构和增加Myc水平而强烈激活端粒酶. E6/E6 AP复合物可能增强推定的DNA结合蛋白的降解,所述DNA结合蛋白可以募集蛋白质,例如组蛋白脱乙酰酶。
英文摘要
Activation of telomerase is a common and specific feature in more than 85% of all cancers. In addition to the reverse transcriptase subunit of telomerase (TERT), the E6 gene of "high risk" human papillomavirus and the c-myc oncogene have been known to activate telomerase. In order to clarify the mechanisms activating telomerase, we examined the actions of these genes in activating telomerase, and elucidated the following points :l. Both HPV16 E6 and c-myc activate telomerase by inducing the expression of TERT.2. Neither E6 nor c-myc can activate telomerase in primary human fibroblasts.3. In primary human mammary epithelial cells (HMEC), E6 can activate telomerase without increasing Myc, while E7 can increase Myc level but cannot activate telomerase. Expression of E6 together with E7 can activate telomerase stronger than E6 alone can.4. With a yeast three hybrid system, cDNAs of novel cellular proteins that can bind to E6/E6AP complexes were isolated, and antisera against some of the proteins were raised.From these results, we led the following hypotheses :l. E6 enables the transcription factor Myc to access TERT locus by changing its chromatin structure.2. In HMEC expressing E6 and E7, E6 and E7 can strongly activate telomerase by opening the chromatin structure and increasing Myc level, respectively.3. E6/E6AP complexes might enhance degradation of a putative DNA binding protein(s) that can recruit proteins such as histone deacetylases.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
Passalaris, T.M.et al.: "The G2 checkpoint is maintained by redundant pathways"Molecular and Cellular Biology. 19. 5872-5881 (1999)
Passalaris, T.M.等人:“G2 检查点是通过冗余途径维持的”分子和细胞生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fujii K. et al: "The Epstein-Barr virus Pol catalytic subunit physically interacts with the BBLF4-BSLF1-BBLF2/3 complex."Journal of Virology. 74. 2550-2557 (2000)
Fujii K. 等人:“Epstein-Barr 病毒 Pol 催化亚基与 BBLF4-BSLF1-BBLF2/3 复合物发生物理相互作用。”病毒学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Development of eradicative cancer treatment based on synthetic lethality of induced cancer stem cells
    • 批准号:
      16H04701
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.73万
    • 财政年份:
      2016
    • 负责人:
      KIYONO Tohru
    • 依托单位:
    Analyzing mechanism of oncogenesis by human papillomavirus
    • 批准号:
      14026065
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $18.24万
    • 财政年份:
      2002
    • 负责人:
      KIYONO Tohru
    • 依托单位:
    国内基金
    海外基金
    METTL3介导HPV16 E6的转录后修饰参与宫颈病变演进的机制研究
    • 批准号:
      2026JJ50335
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      杨文青
    • 依托单位:
    基 于多 价结 合的 自动 化核 酸提 取 方法 用于 HPV E6/E7 mRNA 的实时荧光定量 PCR 检测研究
    E6AP/E6 复合体识别和泛素化p53 的分子机制研究
    靶向宫颈癌E6/E7的抗原肽嵌合型溶瘤腺病毒联合ICB重塑肿瘤免疫微环境的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
    • 依托单位: